The Monash Antibody Technologies Facility (MATF) at the Monash University selected Genetix’ ClonePix FL technology to assist in the identification and isolation of thousands of cell lines for mAb production. ClonePix FL will be mostly used in rare-event cell lines producing phosphopeptide-specific mAbs, according to Alan Sawyer, director of MATF.
